Predictive Oncology (POAI)
(Delayed Data from NSDQ)
$1.34 USD
+0.05 (3.88%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $1.32 -0.02 (-1.49%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
POAI 1.34 +0.05(3.88%)
Will POAI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for POAI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for POAI
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates
POAI: What are Zacks experts saying now?
Zacks Private Portfolio Services
NantHealth, Inc. (NH) Reports Q4 Loss, Tops Revenue Estimates
1Life Healthcare, Inc. (ONEM) Reports Q4 Loss, Tops Revenue Estimates
Other News for POAI
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
3 AI Penny Stocks With Massive Growth Potential: April Edition
Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers
Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript
Predictive Oncology GAAP EPS of -$3.48, revenue of $1.78M